Michael Aye

Prior to joining Applied BioCode, Inc., Dr. Aye was the Technical Director, Assay Development at Focus Diagnostics (a subsidiary of Quest Diagnostics). He developed and commercialized IVD products, including SimplexaTM Mycoplasma pneumoniae assay, Influenza A H1N1, and Flu A/B & RSV assay, as well as Simplexa Direct chemistry and Sample-to-Answer molecular detection system. He has developed and launched over 40 molecular products, including ASR, GPR, RUO, CE IVD, and FDA 510(k) cleared products. Dr. Aye obtained his doctoral degree in Biology from the University of California, Irvine.